Introduction and Overview
Empagliflozin and linagliptin are the two active components in the combination drug Ajaduo 10mg/5mg Tablet. For the management of type 2 diabetes mellitus, it is frequently recommended. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, whereas Empagliflozin is a member of the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. This combo drug functions by assisting in lowering blood sugar levels via various methods of action.
How Does Ajaduo Work?
10/5 mg of Ajaduo Tablet helps treat type 2 diabetes via two distinct mechanisms:
- Empagliflozin: By inhibiting SGLT2 in the kidneys, empagliflozin prevents the reabsorption of glucose and promotes the excretion of extra glucose in the urine. Haemoglobin A1c (HbA1c), a marker of long-term blood sugar control, is reduced as a result, helping to lower blood sugar levels.
- Linagliptin: Linagliptin blocks DPP-4, an enzyme that degrades incretin hormones, to produce its effects. Linagliptin raises the levels of active incretin hormones such glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by inhibiting DPP-4. These hormones increase the release of insulin and decrease the release of glucagon, which aids in controlling blood sugar levels.
Related Product
Ajaduo 10mg/5mg Tablet
Ajaduo 25mg/5mg Tablet
Precautions and Warnings
Prior to using Ajaduo 10mg/5mg Tablet, it’s critical to take the following safety measures into account:
-
- Ajaduo may have an impact on kidney function. Your doctor may need to check your kidney function both before you start taking the medicine and on a regular basis after. Before taking Ajaduo, let your doctor know if you have any kidney issues.
- One of Ajaduo’s main ingredients, empagliflozin, has the potential to lower blood pressure. For patients using blood pressure drugs, this effect can be more noticeable. Regularly check your blood pressure, and let your doctor know if you develop any symptoms like lightheadedness or dizziness.
- While Ajaduo by itself typically does not result in hypoglycemia (low blood sugar), it may raise the risk when combined with other anti-diabetic drugs like insulin or sulfonylureas. It’s crucial to frequently check your blood sugar levels and be informed of the symptoms and signs of hypoglycemia.
- Rare instances of pancreatitis (pancreatic inflammation) associated with the usage of DPP-4 inhibitors have been made. Inform your healthcare practitioner right away if you encounter severe stomach discomfort that doesn’t go away.
Possible Side Effects
Some people may get negative effects after taking Ajaduo 10mg/5mg Tablet. The following are typical adverse effects of Linagliptin with empagliflozin:
- infections of the urinary tract
- more frequent urination
- When used with other anti-diabetic drugs, hypoglycemia
- (Common cold) Nasopharyngitis
- Headache
Typically, these side effects are minor and go away on their own. Notify your healthcare practitioner if you develop any severe or persistent side effects for additional assessment and advice.
Additional Considerations
Here are some extra factors to take into account when using the Ajaduo 10mg/5mg Tablet in addition to the information already mentioned:
- Cardiovascular Effects: Empagliflozin, one of Ajaduo’s active ingredients, has been demonstrated to have positive effects on the cardiovascular system. In individuals with type 2 diabetes and established cardiovascular disease, it has been linked to a decreased risk of cardiovascular events, such as heart attacks and strokes. However, you should speak with your doctor about using Ajaduo to lower your cardiovascular risk.
- Genital Infections: Empagliflozin, an SGLT2 inhibitor, may raise your chance of developing genital infections, including male and female yeast infections and balanitis. Seek medical help if you suffer symptoms like genital irritation, redness, or discharge.
- Hypersensitivity events: Linagliptin, one of the active ingredients in Ajaduo, has occasionally been associated with hypersensitivity events such as redness, edoema, and breathing difficulties. If you experience any symptoms of a hypersensitive reaction, stop taking the drug and get help right once.
- Adherence to Medication: It’s critical to take Ajaduo exactly as directed by your doctor and to follow the suggested dose regimen. The effectiveness of the drug can be impacted and the risk of problems may rise if doses are missed or exceeded.
Frequently Asked Questions (FAQs)
Ajaduo 10mg/5mg Tablet frequently asked questions include the following:
Ajaduo is different from other diabetes drugs in what ways?
Ajaduo combines Linagliptin and Empagliflozin, two distinct drug classes, to decrease blood sugar levels in two separate ways. Empagliflozin works by lessening the kidneys’ ability to reabsorb glucose, whereas Linagliptin improves the body’s inherent capacity to control blood sugar levels. Compared to treatments using a single medication, this combination may provide more advantages.
Ajaduo can be used alone or in conjunction with other diabetes drugs, according to question 2.
Ajaduo can be used alone or in conjunction with other anti-diabetic drugs to treat type 2 diabetes. The decision is based on a number of variables, such as personal preferences, treatment objectives, and healthcare professional advice.
When taking Ajaduo, are there any dietary restrictions?
A balanced and healthy diet should be maintained as part of diabetes care even though there are no special food restrictions related to Ajaduo. A qualified dietician or your healthcare physician can advise you on the best nutritional options to complement your treatment plan.
Ajaduo: Can it lead to weight loss?
Ajaduo’s active ingredient empagliflozin may cause mild weight loss because of the way it works, which encourages the excretion of glucose in the urine. Individual reactions might differ, though, and your doctor should keep a close eye on any weight fluctuations.
Q5: Can people with kidney issues use Ajaduo?
A: Patients with compromised kidney function should use ajaduo with caution. It could be essential to change the dosage or consider alternative forms of therapy. It is critical to communicate any kidney issues or worries you may have to your healthcare physician.
Conclusion
It is typical to prescribe Ajaduo 10mg/5mg Tablet, which contains Linagliptin and Empagliflozin, to treat type 2 diabetes mellitus. It functions by reducing blood sugar levels in a variety of ways. It is crucial to take the medication as directed, to take safety measures, and to notify your doctor of any side effects or concerns. Diabetes can be effectively managed by making lifestyle changes, such as eating healthily and exercising regularly, in addition to taking medication. For personalised counsel and direction tailored to your unique requirements and circumstances, always seek the opinion of a healthcare expert.
